Thyroid hormone receptor mutations found in renal clear cell carcinomas alter corepressor release and reveal helix 12 as key determinant of corepressor specificity

Molecular Endocrinology

Volumn 23, Issue 8, 2009, Pages 1183-1192

  Rosen, Meghan D ^a   Privalsky, Martin L ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

MUTANT PROTEIN; THYROID HORMONE RECEPTOR;

ARTICLE; CLEAR CELL CARCINOMA; GENE MUTATION; HUMAN; KIDNEY CARCINOMA; NONHUMAN; PHENOTYPE; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN BINDING;

CARCINOMA, RENAL CELL; CELL LINE, TUMOR; CLONING, MOLECULAR; GENE EXPRESSION REGULATION, NEOPLASTIC; GENES, DOMINANT; HORMONES; HUMANS; KIDNEY NEOPLASMS; MUTATION; PHENOTYPE; PROTEIN BINDING; PROTEIN STRUCTURE, TERTIARY; RECEPTORS, THYROID HORMONE; REPRESSOR PROTEINS; TRANSCRIPTIONAL ACTIVATION;

PYRONIA TITHONUS;

EID: 67749122138     PISSN: 08888809     EISSN: None     Source Type: Journal    
DOI: 10.1210/me.2009-0126     Document Type: Article

References (48)

1. Yen PM 2001 Physiological and molecular basis of thyroid hormone action. Physiol Rev 81:1097-1142
2. Harvey CB, Williams GR 2002 Mechanism of thyroid hormone action. Thyroid 12:441-446
3. Cheng SY 2000 Multiple mechanisms for regulation of the transcriptional activity of thyroid hormone receptors. Rev Endocr Metab Disord 1:9-18
4. Mangelsdorf DJ, Thummel C, Beato M, Herrlich P, Schütz G, Umesono K, Blumberg B, Kastner P, Mark M, Chambon P, Evans RM 1995 The nuclear receptor superfamily: the second decade. Cell 83:835-839
5. Zhang J, Lazar MA 2000 The mechanism of action of thyroid hormones. Annu Rev Physiol 62:439-466
6. Yen PM, Cheng SY 2003 Germline and somatic thyroid hormone receptor mutations in man. J Endocrinol Invest 26:780-787
7. Cheng SY 2005 Thyroid hormone receptor mutations and disease: beyond thyroid hormone resistance. Trends Endocrinol Metab 16:176-182
8. Chatterjee VK 2001 Resistance to thyroid hormone, and peroxisome-proliferator-activated receptor γ resistance. Biochem Soc Trans 29:227-231
9. Refetoff S 1993 Resistance to thyroid hormone. Clin Lab Med 13:563-581
10. Jepsen K, Rosenfeld MG 2002 Biological roles and mechanistic actions of co-repressor complexes. J Cell Sci 115:689-698
11. Yen PM 2003 Molecular basis of resistance to thyroid hormone. Trends Endocrinol Metab 14:327-333
12. González-Sancho JM, García V, Bonilla F, Muñoz A 2003 Thyroid hormone receptors/THR genes in human cancer. Cancer Lett 192:121-132
13. Barlow C, Meister B, Lardelli M, Lendahl U, Vennström B 1994 Thyroid abnormalities and hepatocellular carcinoma in mice transgenic for v-erbA. EMBO J 13:4241-4250
14. Rietveld LE, Caldenhoven E, Stunnenberg HG 2001 Avian erythroleukemia: a model for corepressor function in cancer. Oncogene 20:3100-3109
15. Ciana P, Braliou GG, Demay FG, von Lindern M, Barettino D, Beug H, Stunnenberg HG 1998 Leukemic transformation by the v-ErbA oncoprotein entails constitutive binding to and repression of an erythroid enhancer in vivo. EMBO J 17:7382-7394
16. Weinberger C, Thompson CC, Ong ES, Lebo R, Gruol DJ, Evans RM 1986 The c-erb-A gene encodes a thyroid hormone receptor. Nature 324:641-646
17. Sap J, Muñ oz A, Damm K, Goldberg Y, Ghysdael J, Leutz A, Beug H, Vennström B 1986 The c-erb-A protein is a high-affinity receptor for thyroid hormone. Nature 324:635-640
18. Lin K, Chen S, Zhu XG, Shieh H, McPhie P, Cheng S 1997 The gene regulating activity of thyroid hormone nuclear receptors is modulated by cell-type specific factors. Biochem Biophys Res Commun 238:280-284
19. Lin KH, Shieh HY, Chen SL, Hsu HC 1999 Expression of mutant thyroid hormone nuclear receptors in human hepatocellular carcinoma cells. Mol Carcinog 26:53-61
20. Lin KH, Zhu XG, Hsu HC, Chen SL, Shieh HY, Chen ST, McPhie P, Cheng SY 1997 Dominant negative activity of mutant thyroid hormone α1 receptors from patients with hepatocellular carcinoma. Endocrinology 138:5308-5315
21. Kamiya Y, Puzianowska-KuznickaM,McPhie P,NaumanJ, Cheng SY,Nauman A 2002 Expression of mutant thyroid hormone nuclear receptors is associated with human renal clear cell carcinoma. Carcinogenesis 23:25-33
22. Puzianowska-Kuznicka M, Krystyniak A, Madej A, Cheng SY, Nauman J 2002 Functionally impaired TR mutants are present in thyroid papillary cancer. J Clin Endocrinol Metab 87:1120-1128
23. Wang CS, Lin KH, Hsu YC 2002 Alterations of thyroid hormone receptor α gene: frequency and association with Nm23 protein expression and metastasis in gastric cancer. Cancer Lett 175:121-127
24. Chan IH, Privalsky ML 2006 Thyroid hormone receptors mutated in liver cancer function as distorted antimorphs. Oncogene 25:3576-3588
25. Lee S, Privalsky ML 2005 Multiple mutations contribute to repression by the v-Erb A oncoprotein. Oncogene 24:6737-6752
26. Farboud B, Privalsky ML 2004 Retinoic acid receptor-α is stabilized in a repressive state by its C-terminal, isotype-specific F domain. Mol Endocrinol 18:2839-2853
27. Privalsky ML 2004 The role of corepressors in transcriptional regulation by nuclear hormone receptors. Annu Rev Physiol 66:315-360
28. Cohen RN, Brzostek S, Kim B, Chorev M, Wondisford FE, Hollenberg AN 2001 The specificity of interactions between nuclear hormone receptors and corepressors is mediated by distinct amino acid sequences within the interacting domains. Mol Endocrinol 15:1049-1061
29. Cohen RN, Putney A, Wondisford FE, Hollenberg AN 2000 The nuclear corepressors recognize distinct nuclear receptor complexes. Mol Endocrinol 14:900-914
30. Goodson M, Jonas BA, Privalsky MA 2005 Corepressors: custom tailoring and alterations while you wait. Nucl Recept Signal 3:e003
31. Collingwood TN, Adams M, Tone Y, Chatterjee VK 1994 Spectrum of transcriptional, dimerization, and dominant negative properties of twenty different mutant thyroid hormone β-receptors in thyroid hormone resistance syndrome. Mol Endocrinol 8:1262-1277
32. Yoh SM, PrivalskyML2000 Resistance to thyroid hormone (RTH) syndrome reveals novel determinants regulating interaction of T3 receptor with corepressor. Mol Cell Endocrinol 159:109-124
33. Jonas BA, Varlakhanova N, Hayakawa F, Goodson M, Privalsky ML 2007 Response of SMRT (silencing mediator of retinoic acid and thyroid hormone receptor) and N-CoR (nuclear receptor corepressor) corepressors to mitogenactivated protein kinase kinase kinase cascades is determined by alternative mRNA splicing. Mol Endocrinol 21:1924-1939
34. Makowski A, Brzostek S, Cohen RN, Hollenberg AN 2003 Determination of nuclear receptor corepressor interactions with the thyroid hormone receptor. Mol Endocrinol 17:273-286
35. Webb P, Anderson CM, Valentine C, Nguyen P, Marimuthu A, West BL, Baxter JD, Kushner PJ 2000 The nuclear receptor corepressor (N-CoR) contains three isoleucine motifs (I/LXXII) that serve as receptor interaction domains (IDs). Mol Endocrinol 14:1976-1985
36. Leo C, Chen JD 2000 The SRC family of nuclear receptor coactivators. Gene 245:1-11
37. McKenna NJ, Xu J, Nawaz Z, Tsai SY, Tsai MJ, O'MalleyBW1999 Nuclear receptor coactivators: multiple enzymes, multiple complexes, multiple functions. J Steroid Biochem Mol Biol 69:3-12
38. McKenna NJ, O'Malley BW 2002 Nuclear receptor coactivators: an update. Endocrinology 143:2461-2465
39. Adams M, Matthews C, Collingwood TN, Tone Y, Beck-Peccoz P, Chatterjee KK 1994 Genetic analysis of 29 kindreds with generalized and pituitary resistance to thyroid hormone. Identification of thirteen novel mutations in the thyroid hormone receptor β gene. J Clin Invest 94:506-515
40. Wu SY, Cohen RN, Simsek E, Senses DA, Yar NE, Grasberger H, Noel J, Refetoff S, Weiss RE 2006 A novel thyroid hormone receptor-β mutation that fails to bind nuclear receptor corepressor in a patient as an apparent cause of severe, predominantly pituitary resistance to thyroid hormone. J Clin Endocrinol Metab 91:1887-1895
41. Farboud B, Hauksdottir H, Wu Y, Privalsky ML 2003 Isotype-restricted corepressor recruitment: a constitutively closed helix 12 conformation in retinoic acid receptors β and γ interferes with corepressor recruitment and prevents transcriptional repression. Mol Cell Biol 23:2844-2858
42. Wong CW, Privalsky ML 1998 Transcriptional silencing is defined by isoformand heterodimer-specific interactions between nuclear hormone receptors and corepressors. Mol Cell Biol 18:5724-5733
43. Jonas BA, Privalsky ML 2004 SMRT and N-CoR corepressors are regulated by distinct kinase signaling pathways. J Biol Chem 279:54676-54686
44. Goodson ML, Jonas BA, Privalsky ML 2005 Alternative mRNA splicing of SMRT creates functional diversity by generating corepressor isoforms with different affinities for different nuclear receptors. J Biol Chem 280:7493-7503
45. Guan KL, Dixon JE 1991 Eukaryotic proteins expressed in Escherichia coli: an improved thrombin cleavage and purification procedure of fusion proteins with glutathione S-transferase. Anal Biochem 192:262-267
46. Yoh SM, Chatterjee VK, Privalsky ML 1997 Thyroid hormone resistance syndrome manifests as an aberrant interaction between mutant T3 receptors and transcriptional corepressors. Mol Endocrinol 11:470-480
47. Lee S, Privalsky ML2005 Heterodimers of retinoic acid receptors and thyroid hormone receptors display unique combinatorial regulatory properties. Mol Endocrinol 19:863-878
48. Goodson ML, Farboud B, Privalsky ML 2007 An improved high throughput protein-protein interaction assay for nuclear hormone receptors. Nucl Recept Signal 5:e002